Delivery Order SPE2DB22D1002-SPE2DB25FKVZ7

Award Date 12/27/24
Potential Completion Date 12/30/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKVZ7
    Delivery Order

This federal contract award, valued at $3,827.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) SPE2DB22D1002, which has a ceiling value of $999,999,999 and runs through November 2026.

The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military healthcare programs globally. The award does not have a set-aside designation, indicating it was competed openly. AmerisourceBergen, as the prime contractor, will be responsible for supplying this medication to the DLA, which oversees medical supply procurement for the U.S. Department of Defense and other federal agencies.

Generated 3/28/25, 10:53 AM